Suppr超能文献

从一项关于脑瘫儿童机器人辅助步态训练的实用、随机、交叉试验(PeLoGAIT)中获得的经验教训。

Lessons learned from conducting a pragmatic, randomized, crossover trial on robot-assisted gait training in children with cerebral palsy (PeLoGAIT).

机构信息

Swiss Children's Rehab, Research Department, University Children's Hospital Zurich, Eleonore Foundation, Affoltern am Albis, Switzerland.

Functioning and Rehabilitation, CAPHRI, Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.

出版信息

J Pediatr Rehabil Med. 2020;13(2):137-148. doi: 10.3233/PRM-190614.

Abstract

PURPOSE

To investigate the effectiveness of outpatient robot-assisted gait training (RAGT) in ambulatory children with spastic cerebral palsy.

METHODS

Children were randomized to two different intervention sequences within a pragmatic crossover design. They performed five weeks of RAGT (3 sessions per week) and five weeks of usual care (UC). Dimension E of the Gross Motor Function Measure-88 (GMFM E) as the primary outcome as well as Dimension D (GMFM D), and timed walking tests were assessed before and after each treatment sequence and after a 5-week follow-up.

RESULTS

The trial was stopped early because of recruitment problems. We included 16 children with a mean age of 11.3 years (6.0-15.3 years). GMFM E median (IQR) change scores were -0.7 (-2.8 to 3.5) after RAGT and 0 (-2.4 to 2.4) after UC. Neither GMFM E nor any secondary outcome measure changed significantly after RAGT or UC, nor were any period, follow-up, or carry-over effects observable.

CONCLUSIONS

RAGT as a single intervention was not effective in improving walking abilities in the included children. It should be embedded in a holistic treatment approach, as it cannot cover all aspects relevant to gait. Furthermore, children's personalized rehabilitation goals should be carefully monitored with individualized measurement instruments.

摘要

目的

研究门诊机器人辅助步态训练(RAGT)对痉挛性脑瘫患儿步行能力的疗效。

方法

采用实用交叉设计,将患儿随机分为两种不同的干预序列。他们进行了五周的 RAGT(每周 3 次)和五周的常规护理(UC)。主要结局是 88 项粗大运动功能测量量表(GMFM)的 E 维度(GMFM E),以及 D 维度(GMFM D)和计时步行测试,分别在每个治疗序列前后以及 5 周随访后进行评估。

结果

由于招募问题,试验提前停止。我们纳入了 16 名平均年龄为 11.3 岁(6.0-15.3 岁)的儿童。RAGT 后 GMFM E 中位数(IQR)变化评分为-0.7(-2.8 至 3.5),UC 后为 0(-2.4 至 2.4)。RAGT 或 UC 后 GMFM E 或任何次要结局测量均无明显变化,也无周期、随访或延续效应。

结论

作为单一干预措施,RAGT 对纳入儿童的步行能力改善无效。它应该嵌入到整体治疗方法中,因为它不能涵盖与步态相关的所有方面。此外,应使用个体化测量工具仔细监测儿童的个性化康复目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb0e/7458505/4c6859c7c996/prm-13-prm190614-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验